GLP-1 agonists
Researchers propose this mechanism could show selective toxicity toward cancer cells because: Tumor cells often lack catalase and other peroxide-neutralizing enzymes Cancer microenvironments contain elevated labile iron levels Normal cells maintain robust antioxidant defenses Clinical Trial Evidence Recent Phase II trials investigating vitamin C injections in cancer treatment have reported early signals that researchers describe as promising, though the evidence remains preliminary: Pancreatic Cancer Study: In a randomized Phase II trial of 34 patients with stage 4 metastatic pancreatic cancer led by Joseph Cullen at the University of IowaPharmacological ascorbate in combination with gemcitabine and nab-paclitaxel published in Redox Biology (2024)participants who received 75 grams (75,000 mg) of IV vitamin C three times weekly alongside standard chemotherapy reached a median overall survival of 16 months, compared with 8.3 months for chemotherapy alone
And then, 170,000, are, are dying of alcohol, use disorder
One reason why this happens is because vitamin B12 is important for making red blood cells, which carry oxygen and help against fatigue
Moreover, knowing a patients societal background is crucial as some patients, particularly those with Multiple Endocrine Neoplasia II syndrome, are at an increased risk for a particular type of adrenal gland tumor (pheochromocytomas) and require further tests before any surgery
Instead, collectively, our analyses suggest that in non-interventional settings where most individuals consume meat daily (75233 g/day for European adults 37 ), clearance by the kidney and not dietary intake of TMAO precursors is the major determinant of fasting circulating TMAO levels and therefore of the excess cardiovascular risk associated with elevated TMAO (vegetarians and strict vegans aside, who are infrequent in the MetaCardis cohort with only 65/1741 participants reporting no red meat consumption)
![Article] Call to avoid buying fake versions of Ozempic and Mounjaro The South African Health Products Regulatory Authority (SAHPRA) has expressed concern at the increasing presence of counterfeit Glucagon-like Peptide (GLP-1) products](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1078755244257788)
